30
Participants
Start Date
December 31, 2025
Primary Completion Date
June 30, 2026
Study Completion Date
September 30, 2026
Lyophilized Recombinant Human Brain Natriuretic Peptide
rh-BNP is reconstituted to a concentration of 10 μg/mL and administered as an initial intravenous bolus of 2 μg/kg over 15 minutes, followed by a continuous infusion at a rate of 0.01 μg/kg/min. Patients should receive at least the first 500μg dose infusion, with a recommended duration of 72 hours. The specific timing of discontinuation will be determined by the attending physician. Prior to rh-BNP administration, measure: PiCCO indices, hemodynamic parameters, venous return, tissue perfusion, echocardiographic parameters, ultrasound indices, 2-hour averaged urine output and fluid balance. Repeat all above-mentioned measurements at 30 minutes post-initiation.
Tibet Kangzhe Pharmaceutical Development Co., Ltd
UNKNOWN
Sichuan Provincial People's Hospital
OTHER